Kodak and Imation keep quiet on rumors

Article

Ongoing rumors about the possibility of a business deal between x-ray film companies Eastman Kodak of Rochester, NY, and Imation of Oakdale, MN, aren't drawing any comment from either of the firms. The rumors have hinted that Kodak might buy part of

Ongoing rumors about the possibility of a business deal between x-ray film companies Eastman Kodak of Rochester, NY, and Imation of Oakdale, MN, aren't drawing any comment from either of the firms. The rumors have hinted that Kodak might buy part of Imation, such as the company's medical imaging business, which includes dry printers, x-ray film, and PACS operations.

Speculation about a possible deal has surfaced on online investment boards and was rife on the exhibit floor at last month's American Healthcare Radiology Administrator's meeting in Las Vegas. Representatives from both Kodak and Imation said that as a matter of corporate policy the companies do not comment on rumors.

If Kodak did buy Imation's medical imaging business, the deal would give Kodak an even stronger position in the x-ray film and PACS markets. Rumors about Kodak have proven wrong in the past, however. Speculation late last year that Kodak would sell its medical imaging business to Johnson & Johnson proved to be untrue (SCAN 1/21/98).

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.